Spotlight: Marga Ortigas-Wedekind, FII Chief Commercial Strategy Officer

The Fogarty Institute continues to build its bench strength with the recent hire of seasoned medtech leader Marga Ortigas-Wedekind as chief commercial strategy officer. With 30 years of experience in medical and health technology companies at a variety of stages of development, her expertise will make her an asset to the entire team, most notably to our entrepreneurs,

Q&A with Ryan Schroeder, Director of the Taft Center for Clinical Research at El Camino Health

As a healthcare organization that is deeply invested in the well-being of its patients, El Camino Health has always strived to be at the forefront of innovation. Therefore, it is not surprising that it is also one of the few community hospitals that boasts a dedicated clinical research program. The effort started informally through the work of its physicians and has since evolved into a fully integrated part of the hospital operations as the Taft Center for Clinical Research.

Fogarty Institute Proud of Increased Role in Successful 2019 Innovation Summit

With a goal of helping bring together investors and collaborators in the global medtech industry and shine a light on continuing education, the Fogarty Institute once again participated in the prestigious MedTech Strategist Innovation Summit San Francisco 2019 on November 18 and 19; this year assuming a larger role as a co-sponsor and co-organizer. As in the past,

START TYPING AND PRESS ENTER TO SEARCH